- Home
- PRLB vs LENZ Comparison
PRLB vs LENZ Comparison
Compare PRLB & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLB
- LENZ
- Stock Information
- Founded
- PRLB 1999
- LENZ 2019
- Country
- PRLB United States
- LENZ United States
- Employees
- PRLB N/A
- LENZ N/A
- Industry
- PRLB Metal Fabrications
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- PRLB Industrials
- LENZ Health Care
- Exchange
- PRLB Nasdaq
- LENZ Nasdaq
- Market Cap
- PRLB 928.0M
- LENZ 819.1M
- IPO Year
- PRLB 2012
- LENZ 2021
- Fundamental
- Price
- PRLB $39.85
- LENZ $30.11
- Analyst Decision
- PRLB Hold
- LENZ Strong Buy
- Analyst Count
- PRLB 3
- LENZ 5
- Target Price
- PRLB $43.00
- LENZ $41.80
- AVG Volume (30 Days)
- PRLB 208.8K
- LENZ 287.8K
- Earning Date
- PRLB 08-01-2025
- LENZ 05-07-2025
- Dividend Yield
- PRLB N/A
- LENZ N/A
- EPS Growth
- PRLB N/A
- LENZ N/A
- EPS
- PRLB 0.60
- LENZ N/A
- Revenue
- PRLB $499,205,000.00
- LENZ N/A
- Revenue This Year
- PRLB $4.18
- LENZ N/A
- Revenue Next Year
- PRLB $4.61
- LENZ $544.79
- P/E Ratio
- PRLB $65.14
- LENZ N/A
- Revenue Growth
- PRLB N/A
- LENZ N/A
- 52 Week Low
- PRLB $25.76
- LENZ $16.28
- 52 Week High
- PRLB $46.73
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- PRLB 58.54
- LENZ 54.68
- Support Level
- PRLB $37.91
- LENZ $28.45
- Resistance Level
- PRLB $39.92
- LENZ $32.02
- Average True Range (ATR)
- PRLB 0.73
- LENZ 2.15
- MACD
- PRLB 0.12
- LENZ -0.09
- Stochastic Oscillator
- PRLB 97.23
- LENZ 41.42
About PRLB Proto Labs Inc. Common stock
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.